Lucy Gentles Bojidar Goranov Elizabeth Matheson Dr Ashleigh Herriott Dr Angelika Kaufmann et al. | Exploring the frequency of Homologous Recombination DNA Repair Dysfunction in Multiple Cancer Types | 2019 |
|
Professor Richard Edmondson Dr Angelika Kaufmann
| Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative | 2017 |
|
Dr Aiste McCormick Dr Peter Donoghue Michelle Dixon Dr Rachel O'Donnell James Murray et al. | Ovarian Cancers Harbour Defects in Non-Homologous End Joining Resulting in Resistance to Rucaparib | 2017 |
|
Dr Rachel O'Donnell Dr Angelika Kaufmann Dr Laura Woodhouse Dr Aiste McCormick Professor Richard Edmondson et al. | Advanced Ovarian Cancer Displays Functional Intratumor Heterogeneity That Correlates to Ex Vivo Drug Sensitivity | 2016 |
|
Dr Aiste McCormick Dr Rachel O'Donnell Dr Angelika Kaufmann
| Phosphatase and Tensin Homolog Is a Potential Target for Ovarian Cancer Sensitization to Cytotoxic Agents | 2016 |
|
Dr Aiste McCormick Dr Peter Donoghue Michelle Dixon Dr Rachel O'Donnell Dr Angelika Kaufmann et al. | Defects in non-homologous end joining pathway in ovarian cancers results in resistance to rucaparib | 2015 |
|
Dr Rachel O'Donnell Dr Angelika Kaufmann Dr Aiste McCormick Professor Nicola Curtin Professor Richard Edmondson et al. | Intra- and inter-tumour heterogeneity in epithelial ovarian cancer: consequences for biomarker dependent stratification of therapies | 2015 |
|
Dr Aiste McCormick Dr Rachel O'Donnell Dr Angelika Kaufmann Professor Richard Edmondson
| Phosphatase and tensin homolog (PTEN) is a potential target for ovarian cancer sensitisation to cytotoxic agents | 2015 |
|
Dr Aiste McCormick Michelle Dixon Dr Rachel O'Donnell Dr Angelika Kaufmann Professor Richard Edmondson et al. | PTEN function is important in determining ovarian cancer sensitivity to cytotoxic agents | 2015 |
|
Dr Angelika Kaufmann Professor Richard Edmondson
| The use of a p53 signature identifies a group of high risk endometrial cancer associated with an excellent prognosis | 2015 |
|
Dr Miranda Patterson Dr Ian Forrest Becci Sharrock Maria Lane Dr Angelika Kaufmann et al. | Assessing the function of homologous recombination DNA repair in malignant pleural effusion (MPE) samples | 2014 |
|
Laura Woodhouse Dr Aiste McCormick Dr Rachel O'Donnell Dr Angelika Kaufmann Professor Richard Edmondson et al. | Development of a Functional Assay to Determine the Nucleotide Excision Repair Status of Epithelial Overian Cancer | 2014 |
|
Dr Rachel O'Donnell Dr Aiste McCormick Dr Asima Mukhopadhyay Michelle Dixon Dr Angelika Kaufmann et al. | The Use of Ovarian Cancer Cells from Patients Undergoing Surgery to Generate Primary Cultures Capable of Undergoing Functional Analysis | 2014 |
|
Dr Angelika Kaufmann Professor Richard Edmondson
| Use of Molecular Markers Improves Prognostic Stratification in High Risk Endometrial Cancer: A Transportec Collaborative Study | 2014 |
|
Dr Rachel O'Donnell Laura Woodhouse Dr Aiste McCormick Dr Asima Mukhopadhyay Michelle Dixon et al. | Functional Intra-Tumour Heterogeneity in Ovarian Cancer: What is a Representative Tumour Sample? | 2013 |
|